Earnings call: GSK reports strong Q3 growth, optimistic for 2024

GSK (GlaxoSmithKline (NYSE:GSK) PLC) has reported a solid performance in its third-quarter earnings call, with CEO Emma Walmsley announcing a 9% sales growth and a 19% profit growth year-to-date. The… [+69425 chars]

Earnings call: GSK reports strong Q3 growth, optimistic for 2024

Earnings call: GSK reports strong Q3 growth, optimistic for 2024

Earnings call: GSK reports strong Q3 growth, optimistic for 2024

Earnings call: GSK reports strong Q3 growth, optimistic for 2024
Earnings call: GSK reports strong Q3 growth, optimistic for 2024
Ads Links by Easy Branches
Play online games for free at games.easybranches.com
Guest Post Services www.easybranches.com/contribute
Organic Chemical Market Expected to Reach $26.19 Billion by 2032, Growing CAGR at 7.3% | Introspective Market Research

Man-Earth system problems and solutions, Part 1